Distal Peripheral Neuropathy in Type 2 Diabetes

Inclusion Criteria: * Men and women, 18-75 years of age, with a history of chronic bilateral neuropathic foot pain (pain, numbness, tingling) secondary to T2DM for the past three months or greater. * Gracely Pain Scale (GPS) rated pain severity at "moderate" or above, documented in 1-week prospective self report symptom diary (SD)(a). * Primary care provider (PCP) verification of T2DM diagnosis, report of neuropathic foot pain. * Successfully complete a mini-mental status exam (obtaining a score of 24 or above). * Must understand and agree to complete daily symptom diaries for the duration of the study. * If on pharmacologic treatment(s) must have 21 days of stable regimen (same drugs, dose \& frequency) prior to enrollment. Exclusion Criteria: * Any acute condition requiring medical care (severe heart disease, uncontrolled hypertension, lung disease, renal failure, foot lesions, sores, ingrown nails, infection etc.). * Use topically applied medications to the lower extremities / feet. * Allergic to smoke * Alcohol and/or substance dependence. * Receiving injectable corticosteroids. * Receiving other complementary therapies such as herbs, massage, acupuncture etc. for foot pain. * Pregnant women. * Relocation or other plans that interfere with attending all of the planned study session and/or recording SD information.